The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort

INTRODUCTION: Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide news and media attention in the treatment of patients with coronavirus disease 2019 (COVID-19). This drug was used on the basis of its antimicrobial and antiviral properties despite lack of definite evidence of cl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Infect Dis Ther
Päätekijät: Abdulrahman, Abdulkarim, AlSayed, Islam, AlMadhi, Marwa, AlArayed, Jumana, Mohammed, Sara Jaafar, Sharif, Aesha Khalid, Alansari, Khadija, AlAwadhi, Abdulla Ismael, AlQahtani, Manaf
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7822757/
https://ncbi.nlm.nih.gov/pubmed/33484407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00397-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia